Fortes HR, Escuissato DL, Araujo Neto CA, Zanetti G, Hochhegger B, et al. Recurrent respiratory papillomatosis: a state-of-the-art review. Respir Med. 2017;126(116):116–21.

Article  PubMed  Google Scholar 

San Giorgi MR, van den Heuvel ER, Tjon Pian Gi RE, Brunings JW, Chirila M, Friedrich G, et al. Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol. 2016;41(5):448–53.

Article  CAS  PubMed  Google Scholar 

Stamataki SNT, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E. Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck. 2007;29(2):155–62.

Article  PubMed  Google Scholar 

Seedat RY. Juvenile-onset recurrent respiratory papillomatosis diagnosis and management - a developing country review. Pediatric Health Med Ther. 2020;11:39–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanchez GI, Jaramillo R, Cuello G, Quintero K, Baena A, O’Byrne A, et al. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head Neck. 2013;35(2):229–34.

Article  PubMed  Google Scholar 

Lepine C, Leboulanger N, Badoual C. Juvenile onset recurrent respiratory papillomatosis: what do we know in 2024? Tumour Virus Res. 2024. https://doi.org/10.1016/j.tvr.2024.200281.

Article  PubMed  PubMed Central  Google Scholar 

Derkay CS, Wikner EE, Pransky S, Best SR, Zur K, Sidell DR, et al. Systemic use of bevacizumab for recurrent respiratory papillomatosis: who, what, where, when, and why? Laryngoscope. 2023;133(1):2.

Article  PubMed  Google Scholar 

Liu Z, Xu J, Liu M, Zhu D, Xiao Y. 155P Systemic bevacizumab in pediatric patients with aggressive recurrent respiratory papillomatosis. ESMO Open. 2024. https://doi.org/10.1016/j.esmoop.2024.102550.

Article  PubMed  PubMed Central  Google Scholar 

Pai S, Muniappan A, Park J, Friedman A, Campbell N, Krantz S, et al. 992O Pembrolizumab for HPV-associated recurrent respiratory papillomatosis. Ann Oncol. 2024;35:S676.

Article  Google Scholar 

So RJ, Hidalgo Lopez JC, Ballestas SA, Klein AM, Steuer C, Shin DM, et al. Efficacy of systemic bevacizumab for recurrent respiratory papillomatosis with pulmonary involvement. Laryngoscope. 2024;134(2):577–81.

Article  CAS  PubMed  Google Scholar 

Tjon Pian Gi R, Ilmarinen T, Van Den Heuvel E, Aaltonen L, Andersen J, Brunings J, et al. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Euro Archi Oto-Rhino-Laryngol. 2013;270:1679–87.

Article  CAS  Google Scholar 

Tran MN, Galt L, Bashirzadeh F. Recurrent respiratory papillomatosis: the role of cidofovir. Respirol Case Rep. 2018;6(8): e00371.

Article  PubMed  PubMed Central  Google Scholar 

Rosenberg T, Philipsen BB, Mehlum CS, Dyrvig A-K, Wehberg S, Chirilǎ M, et al. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis. J Infect Dis. 2019;219(7):1016–25.

Article  PubMed  Google Scholar 

Yiu Y, Fayson S, Smith H, Matrka L. Implementation of routine HPV vaccination in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2019;128(4):309–15.

Article  PubMed  Google Scholar 

Papaioannou V, Lux A, Voigt-Zimmermann S, Arens C. Treatment outcomes of recurrent respiratory papillomatosis: retrospective analysis of juvenile and adult cases. HNO. 2018;66(Suppl 1):7–15.

Article  PubMed  Google Scholar 

Welschmeyer A, Berke GS. An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2021;6(2):226–33.

Article  PubMed  PubMed Central  Google Scholar 

Bertino G, Pedretti F, Mauramati S, Filauro M, Vallin A, Mora F, et al. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies Literature review and multicentre retrospective study. Acta Otorhinolaryngol Ital. 2023. https://doi.org/10.14639/0392-100X-suppl.1-43-2023-14.

Article  PubMed  PubMed Central  Google Scholar 

Goodman E, Reuschenbach M, Kaminski A, Ronnebaum S. Human papillomavirus vaccine impact and effectiveness in six high-risk populations: a systematic literature review. Vaccines. 2022. https://doi.org/10.3390/vaccines10091543.

Article  PubMed  PubMed Central  Google Scholar 

Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22–34.

Article  PubMed  PubMed Central  Google Scholar 

Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol Head Neck Surg. 1995;121(12):1386–91.

Article  CAS  PubMed  Google Scholar 

Armstrong LRPEJD, Reichert M, Phillips DL, Nisenbaum R, Todd NW, Jacobs IN, Inglis AF, Manning SC, Reeves WC. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis. 2000;31(1):107–9.

Article  CAS  PubMed  Google Scholar 

Marsico M, Mehta V, Chastek B, Liaw KL, Derkay C. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex Transm Dis. 2014;41(5):300–5.

Article  PubMed  Google Scholar 

Cristensen P-HJK, Grontved A. Juvenile papillomatosis of the larynx A 45 years’ follow up from the county of Funen Denmark. Acta Otolaryngol. 1984;98:37–9.

Google Scholar 

Lindeberg H, Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965–1984. Clin Otolaryngol Allied Sci. 1990;15(2):125–31.

Article  CAS  PubMed  Google Scholar 

Omland T, Akre H, Vardal M, Brondbo K. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122(7):1595–9.

Article  PubMed  Google Scholar 

Campisi P, Hawkes M, Simpson K. Canadian juvenile onset recurrent respiratory papillomatosis working G The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope. 2010;120(6):1233–45.

Article  PubMed  Google Scholar 

Seedat RY, Schall R. Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis-a South African perspective. Clin Otolaryngol. 2018;43(2):533–7.

Article  CAS  PubMed  Google Scholar 

Oh JK, Choi HY, Han M, Jung YS, Lee SJ, Ki M. Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea. Epidemiol Health. 2021;43: e2021019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novakovic D, Cheng AT, Baguley K, Walker P, Harrison H, Soma M, et al. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates. Laryngoscope. 2016;126(12):2827–32.

Article  PubMed  Google Scholar 

Meites E, Stone L, Amiling R, Singh V, Unger ER, Derkay CS, et al. Significant declines in juvenile-onset recurrent respiratory papillomatosis following human papillomavirus (HPV) vaccine introduction in the United States. Clin Infect Dis. 2021;73(5):885–90.

Article  PubMed  Google Scholar 

Novakovic DBJ, Garland S, Chen A, Zurynski Y, Tabrizi S. An australian national prospective study of the incidence of juvenile onset recurrent respiratory papillomatosis. Intern Med J. 2016;46:23–4.

Article  Google Scholar 

Zurynski YBJML, Novakovic D, Cheng ATL, Booy R, Berkowitz R, Garland SM, Elliott E, Black R. Reduced rates of juvenile onset recurrent respiratory papillomatosis in Australia after implementation of a national HPV vaccination program. Arch Disease Childhood. 2018;103:203.

Google Scholar 

Teutsch SM, Nunez CA, Morris A, Eslick GD, Berkhout A, Novakovic D, et al. Australian paediatric surveillance unit (APSU) annual surveillance report 2021. Commun Dis Intell. 2018;2022:46.

Google Scholar 

Mauz PS, Schafer FA, Iftner T, Gonser P. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis. BMC Infect Dis. 2018;18(1):343.